A new drug formulation and manufacturing platform combines a “digital formulator” with automated tableting to accelerate the development cycle from formulation design through production steps. The work, published in Nature Communications, integrates computational and workflow automation to reduce manual iteration during drug development. The reported concept centers on connecting formulation optimization with downstream manufacturing automation, including self-driving tableting to support consistent compression and scale-relevant process parameters. The overarching aim is to reduce cycle time while improving the reliability of manufacturing-critical attributes. For the industry, the implication is that formulation-development bottlenecks may increasingly be addressed via closed-loop automation rather than only through improved analytics or single-step robotics. Companies will likely watch for how quickly the approach can be adapted across dosage forms and molecule chemistries, and whether it can be translated into regulated CMC workflows at scale.